Hearing Loss News and Research

Latest Hearing Loss News and Research

Studies suggest role for IL-10 in prevention and treatment of neurological disease in newborns

This bacterium, Escherichia coli K1, is the most common cause of meningitis in premature infants and the second most common cause of the disease in newborns. "The ineffectiveness of antibiotics in treating newborns with meningitis and the emergence of antibiotic-resistant strains of bacteria require new strategies," explains Nemani V. Prasadarao, PhD, associate professor of infectious disease at Childrens Hospital Los Angeles.

17 Jun 2010

Fertility drugs cause multiple and premature births

The widespread use of fertility drugs, not just high-tech laboratory procedures, plays a major role in causing multiple births and contributes to the problem of premature birth in the United States, experts said today at the March of Dimes National Communications Advisory Council luncheon.

17 Jun 2010

Xacore signs agreement with ESSE to tackle challenge of military hearing loss

Xacore announces today that they have entered into an agreement with Ellis Services and Solutions Enterprises, LLC headed by retired US Army Four-Star General Larry R. Ellis and his group of experienced professionals to tackle the challenge of military hearing loss. This agreement joins Xacore's leading edge noise protection DSP radio headset technology with the strengths of ESSE's experience in marketing and solutions with the military and government.

17 Jun 2010

GenVec engages Wells Fargo Securities to conduct comprehensive review of strategic alternatives

GenVec, Inc. today announced that it has engaged Wells Fargo Securities, LLC to conduct a comprehensive review of strategic alternatives aimed at enhancing shareholder value.

16 Jun 2010

Hormone that helps regulate blood sugar levels may influence sensitivity to sweet-tasting foods: Study

A hormone that helps to regulate blood sugar levels may also influence a person's sensitivity to sweet-tasting foods, according to a new study from researchers at the University of Maryland School of Medicine. They found that blocking the tongue's ability to respond to the hormone known as glucagon decreases the taste system's sensitivity to sweetness.

16 Jun 2010

Research on genetic mutations could lead to accurate diagnosis of USH, says scientist

Usher syndrome, an inherited condition involving both hearing and vision loss, is not a simply recessively inherited disease, a scientist will tell the annual conference of the European Society of Human Genetics today (Saturday). Dr. Hanno Bolz, Associate Medical Director of the Bioscientia Centre for Human Genetics, Ingelheim, Germany, and active in teaching and research at the University Hospital of Cologne, will say that his team's research challenges the traditional view that USH was inherited as a single gene disorder, and shows that it may result from at least two different genetic mutations.

14 Jun 2010

Otonomy completes $10 million Series A financing with Avalon Ventures

Otonomy, Inc. announced today that it has completed a $10 million Series A financing with Avalon Ventures. Proceeds from the financing will be used to support the ongoing clinical trial for OTO-104 in Meniere's disease, initiate IND-enabling studies for OTO-203, and continue early-stage development of a third program.

11 Jun 2010

Protein IL-10 removes Escherichia coli K1 bacterium from blood and reverses brain damage

A team of researchers at Childrens Hospital Los Angeles (CHLA), along with colleagues from the Keck School of Medicine of the University of Southern California and the Universite Auvergne, France, have discovered an important role for a small, naturally occurring protein called interleukin-10 (IL-10) in removing bacteria from the blood of infected mice and reversing damage to the brain.

11 Jun 2010

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

The World Health Organization (WHO), in consultation with the government of the United Kingdom, has designated the Liverpool School of Tropical Medicine (LSTM) as a WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases.

11 Jun 2010

Sonomax signs MOU with ETS for $750,000 Industrial Research Chair

Sonomax Technologies Inc. signs a memorandum of understanding with the École de Technologie Supérieure (ETS) of the Université du Québec to create a five-year renewable $750,000 Industrial Research Chair to conduct unprecedented development of advanced in-ear technologies.

9 Jun 2010

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.

8 Jun 2010

Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes

VIVUS, Inc. today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The REVIVE-Diabetes study met all three primary endpoints across the two doses studied by demonstrating statistically significant improvement in erectile function as measured by the Sexual Encounter Profile (SEP) and improvements in the International Index of Erectile Function (IIEF) score.

7 Jun 2010

Three in five Americans may develop noise-induced hearing loss

Use of ear bud headphones by youngsters may save your ears from being assaulted by the noise of your teenagers' music or electronic game but are they damaging your child's hearing?

3 Jun 2010

Lumizyme receives FDA approval for patients with late-onset Pompe disease

The U.S. Food and Drug Administration approved Lumizyme (alglucosidase alfa) for patients ages 8 years and older with late-onset (non-infantile) Pompe disease, a rare genetic disorder.

26 May 2010

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia is leading the way in vaccinations to protect children from serious disease. The province is the first in Canada to include Prevnar 13, the vaccine that provides the broadest coverage available against Streptococcus pneumoniae that may cause invasive pneumococcal disease, in the routine child immunization program.

21 May 2010

Millions of Americans continue to risk losing their hearing each day, warns audiologist

May is Better Hearing Month, but millions of Americans are continuing to needlessly risk losing their hearing each day, warns audiologist Dr. Cindy Beyer. "Almost all hearing loss is due to the aging process or to noise, but only noise-induced hearing loss can be prevented," says Dr. Beyer, senior vice president of HearUSA, a nationwide provider of hearing care and hearing aids.

18 May 2010

New way to coax embryonic stem cells and reprogrammed adult cells to develop sensory cells

After ten years of effort, researchers reporting in the May 14th issue of the journal Cell, a Cell Press publication, say they have found a way to coax embryonic stem cells as well as reprogrammed adult cells to develop into sensory cells that normally reside in the mammalian inner ear. Those mechanosensitive sensory hair cells are the linchpin of hearing and balance.

14 May 2010

Stanford researchers make hair-cell-like cells in a petri dish

Deep inside the ear, specialized cells called hair cells detect vibrations in the air and translate them into sound. Ten years ago, Stefan Heller, PhD, professor of otolaryngology at the Stanford University School of Medicine, came up with the idea that if you could create these cells in the laboratory from stem cells, it would go a long way toward helping scientists understand the molecular basis of hearing in order to develop better treatments for deafness.

14 May 2010

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it will initiate a Phase IIb clinical trial for ZoraxelTM in the treatment of erectile dysfunction (ED).

13 May 2010

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.

12 May 2010

Hearing Loss News and Research

Latest Hearing Loss News and Research

Studies suggest role for IL-10 in prevention and treatment of neurological disease in newborns

Fertility drugs cause multiple and premature births

Xacore signs agreement with ESSE to tackle challenge of military hearing loss

GenVec engages Wells Fargo Securities to conduct comprehensive review of strategic alternatives

Hormone that helps regulate blood sugar levels may influence sensitivity to sweet-tasting foods: Study

Research on genetic mutations could lead to accurate diagnosis of USH, says scientist

Otonomy completes $10 million Series A financing with Avalon Ventures

Protein IL-10 removes Escherichia coli K1 bacterium from blood and reverses brain damage

LSTM designated WHO Collaborating Centre for Evidence Synthesis for Infectious and Tropical Diseases

Sonomax signs MOU with ETS for $750,000 Industrial Research Chair

Health Canada approves Novartis' Menveo for prevention of meningococcal disease

Positive results from VIVUS' Phase 3 study of avanafil for ED in men with diabetes

Three in five Americans may develop noise-induced hearing loss

Lumizyme receives FDA approval for patients with late-onset Pompe disease

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

Millions of Americans continue to risk losing their hearing each day, warns audiologist

New way to coax embryonic stem cells and reprogrammed adult cells to develop sensory cells

Stanford researchers make hair-cell-like cells in a petri dish

Rexahn Pharmaceuticals announces Phase IIb clinical trial of Zoraxel for ED

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Hearing Loss News and Research

Latest Hearing Loss News and Research

Innovation in neuroscience drug discovery - eBook eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in